Your browser doesn't support javascript.
loading
Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey).
Teramoto, Tamio; Ogawa, Hisao; Ueshima, Hirotsugu; Okada, Yasushi; Haze, Kazuo; Matsui, Shigeyuki; Fujikawa, Keita; Hashimoto, Takamasa; Sakui, Sho; Nishimura, Kunihiko; Kajita, Mika; Horimoto, Atsushi; Fernandez, Jovelle.
Affiliation
  • Teramoto T; Teikyo Academic Research Center (TARC), Teikyo University, Tokyo, Japan.
  • Ogawa H; Kumamoto University, Kumamoto, Japan.
  • Ueshima H; NCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.
  • Okada Y; Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Haze K; Department of Cardiology, Kashiwara Municipal Hospital, Kashiwara, Japan.
  • Matsui S; Department of Biostatistics, Nagoya University, Nagoya, Japan.
  • Fujikawa K; Japan Medical Office, Takeda Pharmaceutical Company, Tokyo, Japan.
  • Hashimoto T; Statistical and Quantitative Sciences, Takeda Pharmaceutical Company, Osaka, Japan.
  • Sakui S; Statistical and Quantitative Sciences, Takeda Pharmaceutical Company, Osaka, Japan.
  • Nishimura K; Japan Medical Office, Takeda Pharmaceutical Company, Tokyo, Japan.
  • Kajita M; Japan Medical Office, Takeda Pharmaceutical Company, Tokyo, Japan.
  • Horimoto A; Department of Biometrics, PRA Health Sciences, Osaka, Japan.
  • Fernandez J; Japan Medical Office, Takeda Pharmaceutical Company, Tokyo, Japan.
Expert Opin Drug Saf ; 22(1): 81-90, 2023 Jan.
Article de En | MEDLINE | ID: mdl-35772177

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Hypertriglycéridémie / Acides gras omega-3 / Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase Type d'étude: Etiology_studies / Risk_factors_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Expert Opin Drug Saf Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Hypertriglycéridémie / Acides gras omega-3 / Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase Type d'étude: Etiology_studies / Risk_factors_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Expert Opin Drug Saf Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni